Fresenius Medical Care Investors Might be Upset by New U.S. Payment Rates
Dow Jones
Jun 25
1217 GMT - Fresenius Medical Care investors might be disappointed by a smaller-than-expected increase in 2027 payment rates proposed by the U.S. Centers for Medicare & Medicaid Services, UBS analysts say in a research note. The CMS on Wednesday said it proposed to increase payments to facilities where Medicare beneficiaries with end-stage renal disease get dialysis services by 1.1% next year. The proposed raise for the base rate is roughly half of what investors likely anticipated and well below prior years, according to UBS. Shares in Fresenius Medical Care fall 2.8%. (adria.calatayud@wsj.com)
(END) Dow Jones Newswires
June 25, 2026 08:17 ET (12:17 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.